Conveniently left out any questions related to the rock bottom raise and butchered R+D refund. Im sure there would have been more than a few. Are ASX having a closer look?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025